Sandy Spring Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$799K Sell
8,890
-4,073
-31% -$364K 0.03% 246
2024
Q4
$1.04M Sell
12,963
-1,280
-9% -$111K 0.04% 233
2024
Q3
$1.28M Buy
14,243
+1,004
+8% +$84.5K 0.05% 209
2024
Q2
$1.04M Buy
13,239
+41
+0.3% +$3.36K 0.05% 220
2024
Q1
$1.15M Sell
13,198
-846
-6% -$72.2K 0.05% 211
2023
Q4
$1.16M Sell
14,044
-731
-5% -$55.7K 0.06% 201
2023
Q3
$1.16M Sell
14,775
-3,438
-19% -$288K 0.06% 190
2023
Q2
$1.6M Sell
18,213
-172
-0.9% -$14.8K 0.09% 179
2023
Q1
$1.48M Sell
18,385
-458
-2% -$37.3K 0.08% 181
2022
Q4
$1.46M Sell
18,843
-1,043
-5% -$84.5K 0.09% 173
2022
Q3
$1.6M Buy
19,886
+595
+3% +$53.5K 0.1% 163
2022
Q2
$1.73M Sell
19,291
-45
-0.2% -$4.56K 0.1% 168
2022
Q1
$2.15M Sell
19,336
-610
-3% -$64.4K 0.11% 160
2021
Q4
$2.06M Sell
19,946
-501
-2% -$58K 0.1% 163
2021
Q3
$2.56M Sell
20,447
-370
-2% -$47.9K 0.14% 147
2021
Q2
$2.58M Buy
20,817
+239
+1% +$30K 0.14% 143
2021
Q1
$2.43M Sell
20,578
-495
-2% -$58K 0.14% 144
2020
Q4
$2.47M Buy
21,073
+170
+0.8% +$18.7K 0.15% 137
2020
Q3
$2.17M Buy
20,903
+36
+0.2% +$3.62K 0.15% 136
2020
Q2
$1.91M Buy
20,867
+1,055
+5% +$101K 0.14% 139
2020
Q1
$1.79M Buy
19,812
+271
+1% +$28.8K 0.16% 135
2019
Q4
$2.22M Buy
19,541
+22
+0.1% +$2.41K 0.16% 138
2019
Q3
$2.12M Buy
19,519
+893
+5% +$93.2K 0.17% 133
2019
Q2
$1.81M Sell
18,626
-345
-2% -$31.5K 0.15% 148
2019
Q1
$1.73M Sell
18,971
-3,769
-17% -$337K 0.15% 147
2018
Q4
$2.07M Sell
22,740
-444
-2% -$41.5K 0.2% 122
2018
Q3
$2.28M Sell
23,184
-300
-1% -$27.7K 0.19% 136
2018
Q2
$2.01M Sell
23,484
-800
-3% -$66.8K 0.17% 148
2018
Q1
$1.95M Buy
24,284
+854
+4% +$70.4K 0.17% 144
2017
Q4
$1.89M Sell
23,430
-1,102
-4% -$88.3K 0.17% 145
2017
Q3
$1.91M Sell
24,532
-285
-1% -$23.7K 0.18% 142
2017
Q2
$2.2M Sell
24,817
-85
-0.3% -$7.17K 0.22% 131
2017
Q1
$2.01M Sell
24,902
-225
-0.9% -$17.6K 0.2% 139
2016
Q4
$1.79M Buy
25,127
+15
+0.1% +$1.18K 0.19% 148
2016
Q3
$2.17M Buy
25,112
+133
+0.5% +$11.6K 0.23% 118
2016
Q2
$2.17M Sell
24,979
-8,688
-26% -$703K 0.25% 111
2016
Q1
$2.52M Buy
33,667
+13,730
+69% +$1.03M 0.29% 91
2015
Q4
$1.53M Sell
19,937
-982
-5% -$73.9K 0.18% 138
2015
Q3
$1.4M Sell
20,919
-5,100
-20% -$376K 0.17% 144
2015
Q2
$1.93M Sell
26,019
-773
-3% -$59.1K 0.22% 117
2015
Q1
$2.09M Sell
26,792
-1,353
-5% -$103K 0.24% 108
2014
Q4
$2.03M Sell
28,145
-63
-0.2% -$4.38K 0.24% 110
2014
Q3
$1.75M Sell
28,208
-1,125
-4% -$71.5K 0.22% 122
2014
Q2
$1.87M Sell
29,333
-270
-0.9% -$16.4K 0.23% 116
2014
Q1
$1.82M Sell
29,603
-131
-0.4% -$7.63K 0.28% 108
2013
Q4
$1.71M Sell
29,734
-3,035
-9% -$172K 0.24% 117
2013
Q3
$1.75M Sell
32,769
-375
-1% -$20.2K 0.26% 109
2013
Q2
$1.71M Buy
+33,144
New +$1.64M 0.27% 105

Other funds holding MDT

Sandy Spring Bank's MDT Position: Q1 2025 in Review

Sandy Spring Bank reduced its Medtronic (MDT) stake by 31% in Q1 2025, selling an estimated $364K and leaving 8,890 shares worth $799K. The position accounts for 0.03% of the portfolio, ranked #246.

Sandy Spring Bank first reported a position in MDT in Q2 2013 and has held it in 48 quarters since. The position peaked at $2.58M in Q2 2021. 2,171 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Sandy Spring Bank held 8,890 shares of Medtronic worth $799K as of Q1 2025.
  • Sandy Spring Bank sold 4,073 Medtronic shares in Q1 2025, an estimated $364K.
  • Medtronic made up 0.03% of Sandy Spring Bank's portfolio in Q1 2025, its #246 holding.
  • Sandy Spring Bank first reported a position in Medtronic in Q2 2013 and has held it in 48 quarters since.
  • Sandy Spring Bank's Medtronic position peaked at $2.58M in Q2 2021.
  • 2,171 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.